A Study of Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol

Completed · Phase 3 · Has a placebo group

Conditions studied: Hyperlipidemia

In brief

The Torcetrapib project was terminated on December 2, 2006 due to safety findings. A study to look at lipid levels in subjects taking the study drug, Atorvastatin alone or placebo.

Key facts

Study ID

NCT00138762

Run by

Pfizer

People needed

3800

Starts

2004-07-01

Expected to finish

2006-08-01

Last updated by the study team

2012-02-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• subjects with elevated cholesterol

You may not qualify if…

• Women who are pregnant or lactating, or planning to become pregnant.
• Intolerance to statin therapy resulting in withdrawal
• Subjects taking any drugs known to be associated with an increased risk of myositis in combination with HMG-CoA reductase inhibitors
• Subjects with any other medical condition or laboratory abnormality which could affect subject safety, preclude evaluation of response, or render unlikely that the subject would complete the study

Where it is running

• Pfizer Investigational Site — Mesa, Arizona, United States
• Pfizer Investigational Site — Oro Valley, Arizona, United States
• Pfizer Investigational Site — Phoenix, Arizona, United States
• Pfizer Investigational Site — Sun City, Arizona, United States
• Pfizer Investigational Site — Little Rock, Arkansas, United States
• Pfizer Investigational Site — Anaheim, California, United States
• Pfizer Investigational Site — Carmichael, California, United States
• Pfizer Investigational Site — Concord, California, United States
• Pfizer Investigational Site — Greenbrae, California, United States
• Pfizer Investigational Site — Los Angeles, California, United States
• Pfizer Investigational Site — Mission Viejo, California, United States
• Pfizer Investigational Site — Sacramento, California, United States
• Pfizer Investigational Site — Santa Ana, California, United States
• Pfizer Investigational Site — Stockton, California, United States
• Pfizer Investigational Site — Thouasand Oaks, California, United States
• Pfizer Investigational Site — Tustin, California, United States
• Pfizer Investigational Site — Upland, California, United States
• Pfizer Investigational Site — Walnut Creek, California, United States
• Pfizer Investigational Site — Westlake Village, California, United States
• Pfizer Investigational Site — Boulder, Colorado, United States
• Pfizer Investigational Site — Waterbury, Connecticut, United States
• Pfizer Investigational Site — Newark, Delaware, United States
• Pfizer Investigational Site — Coral Gables, Florida, United States
• Pfizer Investigational Site — Ft. Pierce, Florida, United States
• Pfizer Investigational Site — Mobile, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.